HLK Biotech Holding Group, Inc.
HLK Biotech Holding Group, Inc. (AMHD) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
amhd · pe ratio · data through Jun 8, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
HLK Biotech Holding Group, Inc.You AMHD | $0M | N/A | — | — |
 Calithera Biosciences, Inc. CALA | $0M | N/A | — | -$3.78 |
 CannAmerica Brands Corp. CNNXF | $0M | N/A | — | -$0.06 |
 DMK Pharmaceuticals Corporation DMKPQ | $0M | N/A | — | -$12.37 |
 eFFECTOR Therapeutics, Inc. EFTR | $0M | N/A | — | -$16.37 |
 Ingen Technologies, Inc. IGNT | $0M | N/A | — | -$0.00 |
 BioELife Corp. LITH | $0M | N/A | — | -$0.13 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for HLK Biotech Holding Group, Inc. (AMHD) measures how much investors pay for each dollar of the company's trailing earnings. AMHD's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of —.
Frequently asked questions
AMHD pe ratio · 6 questionsAMHD's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of —. Data sourced from Financial Modeling Prep via AMHD's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · HLK Biotech Holding Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08